252 filings
Page 9 of 13
NT 10-Q
4wivt
14 May 13
Notice of late quarterly filing
12:00am
8-K
mea2djmb
8 Mar 13
Unregistered Sales of Equity Securities
12:00am
424B3
1mh1teoexd skth
5 Mar 13
Prospectus supplement
12:00am
8-K
mtozow2thnzb7c6fh6nc
4 Mar 13
Cellceutix Signs with Leading Cancer Center For Licensing New Drug
12:00am
EFFECT
awyq6nw627by3rm1wots
14 Feb 13
Notice of effectiveness
12:00am
CORRESP
d17v4p
13 Feb 13
Correspondence with SEC
12:00am
CORRESP
vxzgvai4d8 5l12aog8p
12 Feb 13
Correspondence with SEC
12:00am
UPLOAD
b6z1abasqee fpu
12 Feb 13
Letter from SEC
12:00am
CORRESP
95afrlw871mler2xza
8 Feb 13
Correspondence with SEC
12:00am
S-3
ypfom83 2g6e
22 Jan 13
Shelf registration
12:00am
8-K
a3819s7nnwn
8 Jan 13
Termination of a Material Definitive Agreement
12:00am
8-K
x74pakb0yn 7uxg2
27 Dec 12
Regulation FD Disclosure
12:00am
8-K
uy3zq8h zz529e
26 Dec 12
Cellceutix Comments on New York Times Article Heralding p53 Drugs as the New Age in Cancer Research
12:00am
8-K
dvrp 5j3xhsj5n4
10 Dec 12
Entry into a Material Definitive Agreement
12:00am
NT 10-Q
wz7gr14htm3toxuh5roq
13 Nov 12
Notice of late quarterly filing
12:00am
NT 10-K
12laq4uyigl2qf8t6mg
28 Sep 12
Notice of late annual filing
12:00am